ReviewBiomedicines2026

Association Between SGLT2 Inhibitor Use and Hepatocellular Carcinoma Risk in Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Jing-Hong Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.